Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Extramedullary Plasmacytoma

Stichting European Myeloma NetworkSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Extramedullary Plasmacytoma cohort.

Asset / SponsorPhaseRating
Inno-206
Stichting European Myeloma Network
Phase 3BB
DEXAMETHASONE
Stichting European Myeloma Network
Phase 3BB
Cyclophosphamide
Stichting European Myeloma Network
Phase 3BB
Bortezomib
Stichting European Myeloma Network
Phase 3BB
ETOPOSIDE
Margarida Magalhaes-Silverman
Phase 2B

View all 24 →

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →